Suchergebnisse - "Tavakolpour, Soheil"

PubPharm (8)

1

Iranian guideline for rituximab therapy in pemphigus patients

enthalten in: Dermatologic therapy | 2019

von Daneshpazhooh, M. | Balighi, K. | Mahmoudi, H. | +12

2

Comparing the short-term therapeutic effects and safety profiles of rituximab therapy in pemphigus vulgaris patients either early treated or later than six months

enthalten in: The Journal of dermatological treatment | 2019

von Balighi, K. | Daneshpazhooh, M. | Akbari, Z. | +3

3

Rituximab as an effective and probably safe treatment for granulomatosis with polyangiitis (Wegener's Granulomatosis)

enthalten in: International immunopharmacology | 2019

von Tavakolpour, S. | Alesaeidi, S.

4

"Change over time in the treatment of pemphigus vulgaris between 2004 and 2016 in Iran" : A multiple cross-sectional study

enthalten in: Dermatologic therapy | 2019

von Salarvand, F. | Fatehi, Z. | Shahali, M. | +7

5

Comparing early and late treatments with rituximab in pemphigus vulgaris : which one is better?

enthalten in: Archives of dermatological research | 2019

von Balighi, K. | Daneshpazhooh, M. | Mahmoudi, H. | +8

6

Anti-desmoglein-1 levels as predictor of prednisolone tapering in pemphigus vulgaris patients treated with rituximab

enthalten in: Dermatologic therapy | 2018

von Balighi, K. | Sakhi, R. | Daneshpazhooh, M. | +3

7

Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention : Lessons learned from nucleos(t)ide analogues therapy

enthalten in: Immunology letters | 2017

von Tavakolpour, S. | Mirsafaei, H. | Elkaei Behjati, S. | +3

8

Rituximab administration in a patient with pemphigus vulgaris following reactivation of occult hepatitis B virus infection

enthalten in: Dermatology online journal | 2017

von Tavakolpour, S. | Soori, T. | Noormohammadpour, P. | +3

1
[1]